In two major COVID-19 developments today, the World Health Organization (WHO) updated its mask guidance, urging countries with widespread transmission to encourage mask...
We’ve been writing about hydroxychloroquine for at least 3 months now. During the time, we shared with you anecdotal evidence from doctors and patients...
The results of an eagerly anticipated randomized controlled trial indicate the antimalaria drug hydroxychloroquine was ineffective at preventing symptoms of COVID-19 in people...
Results of the phase III Inter-B-NHL-ritux 2010 clinical trial reported today in the New England Journal of Medicine show 95 percent three-year survival...
The editors of The Lancet yesterday issued a statement acknowledging the criticism of a recent study that concluded that the antimalaria drugs hydroxychloroquine...
Filip B. Maciejewski1,2,3, Zoltán Zimborás4,5,6, and Michał Oszmaniec2,3
1University of Warsaw, Faculty of Physics, Ludwika Pasteura 5, 02-093 Warszawa, Poland2International Centre for Theory of...